Latest filing published 02 Jun 2020 for Genocea Biosciences, INC..
Insider track record
Narinderjeet Singh: trading record in brief
Narinderjeet Singh discloses dealings in Genocea Biosciences, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 18 March 2019 to 1 June 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 June 2020, the filings show a share grant in Genocea Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Narinderjeet Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,365 shares0Common StockSEC:0001457612-20-000080:0
- 15,536 shares0Common StockSEC:0001457612-20-000033:0
- 7,291 shares@ US$0.5433.5% of flowCommon StockSEC:0001457612-19-000068:0
- 7,291 shares@ US$0.5433.3% of flowCommon StockSEC:0001457612-19-000049:0
- 7,291 shares@ US$0.5433.2% of flowCommon StockSEC:0001457612-19-000040:0
5 of 5 declarations
